Securities Registration: Employee Benefit Plan (s-8)
14 2월 2023 - 6:39AM
Edgar (US Regulatory)
As filed with the Securities and Exchange Commission on February 13,
2023
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OF 1933
PLURI INC.
(Exact name of registrant as specified in its charter)
Nevada |
|
98-0351734 |
(State or other jurisdiction of
incorporation or organization) |
|
(I.R.S. Employer
Identification No.) |
MATAM Advanced Technology Park,
Building No. 5, Haifa, Israel |
|
3508409 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
Pluri Inc. 2016
Equity Compensation Plan
(Full title of the plan)
Nevada Agency and Transfer Company
50 West Liberty Street, Suite 880
Reno, NV 89501
(Name and address of agent for service)
(775) 322-0626
(Telephone number, including area code, of agent
for service)
Copy to:
Oded Har-Even
Howard E. Berkenblit
Ron Ben-Bassat
Sullivan & Worcester LLP
1633 Broadway
New York, NY 10019
Tel: (212) 660-3000
Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated non-accelerated filer, smaller reporting company, or an emerging growth company. See definitions
of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging
growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☐ |
Accelerated filer ☐ |
Non-accelerated filer ☒ |
Smaller reporting company ☒ |
|
Emerging growth company ☐ |
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
EXPLANATORY
NOTE
On
June 29, 2016, Pluri Inc., or the Company, filed a Registration Statement on Form S-8 (File No. 333-212299), or the Original Registration
Statement, with the Securities and Exchange Commission, or the Commission, to register an aggregate of 2,614,197 common shares
of the Company, or the Common Shares, that may be issued pursuant to the Company’s 2016 Equity Compensation Plan, or the 2016 Plan.
On May 8, 2017, the Company
filed a Registration Statement on Form S-8 (File No. 333-217770), or the Second Registration Statement,
with the Commission to register an additional 252,700 Common Shares that may be issued pursuant to the 2016 Plan.
On February 6, 2018, the Company
filed a Registration Statement on Form S-8 (File No. 333-222888), or the Third Registration Statement, with the Commission to register
an additional 345,000 Common Shares that may be issued pursuant to the 2016 Plan.
On February 6, 2019, the Company
filed a Registration Statement on Form S-8 (File No. 333-229535), or the Fourth Registration Statement, with the Commission to register
an additional 345,000 Common Shares that may be issued pursuant to the 2016 Plan.
On September 9, 2020,
the Company filed a Registration Statement on Form S-8 (File No. 333-248686), or the Fifth Registration Statement, with the
Commission to register an additional 150,000 Common Shares that may be issued pursuant to the 2016 Plan.
Pursuant to the 2016 Plan,
the number of Common Shares made available under the 2016 Plan shall not exceed 2.75% of the number of Common Shares issued and outstanding
on a fully diluted basis on the immediately preceding December 31.
The
Company is filing this Registration Statement on Form S-8 to register an additional 1,800,000 Common Shares which
may be issued in connection with securities awards which may hereafter be granted under the 2016 Plan.
Pursuant to General Instruction
E to Form S-8, the contents of the Original Registration Statement, the Second Registration Statement, the Third Registration Statement,
the Fourth Registration Statement and the Fifth Registration Statement, or collectively, the Prior Registration Statements, are incorporated
herein by reference, except for Item 3 and Item 8 of Part II of the Prior Registration Statements, which are being updated by this registration
statement.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation
of Documents by Reference.
The following additional documents,
which have been filed by the Company with the Commission under the Securities Exchange Act of 1934, as amended, or the Exchange Act,
are incorporated by reference in and made a part of this registration statement, as of their respective dates:
(a) Our Annual Report on Form 10-K for the year ended June 30, 2022 filed with the SEC on September 21, 2022;
(b) Our Quarterly Reports
on Form 10-Q for the quarters ended September 30, 2022 and December 31, 2022, as filed with the SEC on November 10, 2022, and February
13, 2023, respectively;
(c) Our Current Reports
on Form 8-K filed with the SEC on July
13, 2022, July 25,
2022, September 29,
2022, October 13, 2022, December
19, 2022, December 28,
2022, January 24, 2023
and February 6, 2023; and
(d) The description of the
Company’s Common Stock contained in the Registration Statement on Form 8-A filed with the
Commission on December 10, 2007, under the Exchange Act, including any amendment or report filed or to be filed for the purpose of updating
such description.
In addition to the foregoing,
all documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act subsequently filed
by the Company prior to the filing of a post-effective amendment which indicates that all securities offered hereunder have been sold
or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be part hereof
from the date of filing of such documents and reports.
Any statement contained in
a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of
this registration statement to the extent that a statement herein, or in any subsequently filed document which also is or is deemed to
be incorporated by reference, modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed,
except as so modified or superseded, to constitute a part of this Registration Statement.
Item 8. Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities
Act, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and
has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Haifa,
Israel, on February 13, 2023.
|
By: |
/s/ Yaky Yanay |
|
|
Yaky Yanay |
|
|
Chief Executive Officer |
POWER OF ATTORNEY AND SIGNATURES
We, the undersigned officers
and directors of Pluri Inc., hereby constitute and appoint Yaky Yanay and Chen Franco-Yehuda and each of them singly, our true and lawful
attorneys-in-fact, with full power to them in any and all capacities, to sign any and all amendments to this registration statement on
Form S-8 (including any post-effective amendments thereto), and to file the same, with exhibits thereto and other documents in connection
therewith, with the Commission, hereby ratifying and confirming all that each of said attorneys-in-fact may do or cause to be done by
virtue hereof.
Pursuant to the requirements
of the Securities Act, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
Signature |
|
Title |
|
Date |
|
|
|
|
|
/s/ Yaky Yanay |
|
Chief Executive Officer, President and Director |
|
February 13, 2023 |
Yaky Yanay |
|
(Principal Executive Officer) |
|
|
|
|
|
|
|
/s/ Chen Franco-Yehuda |
|
Chief Financial Officer and |
|
February 13, 2023 |
Chen Franco-Yehuda |
|
(Principal Financial and Accounting Officer) |
|
|
|
|
|
|
|
/s/ Zami Aberman |
|
Chairman of the Board of Directors |
|
February 13, 2023 |
Zami Aberman |
|
|
|
|
|
|
|
|
|
/s/ Doron Birger |
|
Director |
|
February 13, 2023 |
Doron Birger |
|
|
|
|
|
|
|
|
|
/s/ Rami Levi |
|
Director |
|
February 13, 2023 |
Rami Levi |
|
|
|
|
|
|
|
|
|
/s/ Prof. Varda Shalev |
|
Director |
|
February 13, 2023 |
Prof. Varda Shalev |
|
|
|
|
|
|
|
|
|
/s/ Maital Shemesh-Rasmussen |
|
Director |
|
February 13, 2023 |
Maital Shemesh-Rasmussen |
|
|
|
|
II-2
Pluristem Therapeutics (NASDAQ:PSTI)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025
Pluristem Therapeutics (NASDAQ:PSTI)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025